194 related articles for article (PubMed ID: 22978399)
1. Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.
Narce M; Bellenger J; Rialland M; Bellenger S
Curr Drug Metab; 2012 Dec; 13(10):1454-63. PubMed ID: 22978399
[TBL] [Abstract][Full Text] [Related]
2. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.
Kurikawa N; Takagi T; Wakimoto S; Uto Y; Terashima H; Kono K; Ogata T; Ohsumi J
Biol Pharm Bull; 2013; 36(2):259-67. PubMed ID: 23370355
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
Dobrzyn A; Ntambi JM
Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
[TBL] [Abstract][Full Text] [Related]
4. [Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract].
Chen C; Hu YY; Feng Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):545-548. PubMed ID: 30317781
[TBL] [Abstract][Full Text] [Related]
5. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.
Ntambi JM
J Lipid Res; 1999 Sep; 40(9):1549-58. PubMed ID: 10484602
[TBL] [Abstract][Full Text] [Related]
6. Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease.
Zivkovic AM; Bruce German J; Esfandiari F; Halsted CH
Alcohol Clin Exp Res; 2009 Apr; 33(4):751-8. PubMed ID: 19170661
[TBL] [Abstract][Full Text] [Related]
7. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
8. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism.
Flowers MT; Ntambi JM
Curr Opin Lipidol; 2008 Jun; 19(3):248-56. PubMed ID: 18460915
[TBL] [Abstract][Full Text] [Related]
9. miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1.
Liu XL; Cao HX; Wang BC; Xin FZ; Zhang RN; Zhou D; Yang RX; Zhao ZH; Pan Q; Fan JG
World J Gastroenterol; 2017 Dec; 23(46):8140-8151. PubMed ID: 29290651
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and physiological function of stearoyl-CoA desaturase.
Paton CM; Ntambi JM
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E28-37. PubMed ID: 19066317
[TBL] [Abstract][Full Text] [Related]
11. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
12. Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms.
Heinemann FS; Ozols J
Prostaglandins Leukot Essent Fatty Acids; 2003 Feb; 68(2):123-33. PubMed ID: 12538076
[TBL] [Abstract][Full Text] [Related]
13. A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension.
Bellenger J; Bellenger S; Clément L; Mandard S; Diot C; Poisson JP; Narce M
FASEB J; 2004 Apr; 18(6):773-5. PubMed ID: 14977874
[TBL] [Abstract][Full Text] [Related]
14. Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines.
Huang LL; Wan JB; Wang B; He CW; Ma H; Li TW; Kang JX
Prostaglandins Leukot Essent Fatty Acids; 2013 May; 88(5):347-53. PubMed ID: 23474173
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
Yokozawa J; Sasaki T; Ohwada K; Sasaki Y; Ito JI; Saito T; Kawata S
J Gastroenterol; 2009; 44(6):583-91. PubMed ID: 19365601
[TBL] [Abstract][Full Text] [Related]
16. Role of hepatic desaturases in obesity-related metabolic disorders.
Bjermo H; Risérus U
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):703-8. PubMed ID: 20823776
[TBL] [Abstract][Full Text] [Related]
17. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model for mammary fatty acid synthesis and triglyceride assembly: the role of stearoyl CoA desaturase (SCD).
Shorten PR; Pleasants TB; Upreti GC
J Dairy Res; 2004 Nov; 71(4):385-97. PubMed ID: 15605704
[TBL] [Abstract][Full Text] [Related]
19. Stearoyl-CoA desaturase: a vital checkpoint in the development and progression of obesity.
Poudyal H; Brown L
Endocr Metab Immune Disord Drug Targets; 2011 Sep; 11(3):217-31. PubMed ID: 21831035
[TBL] [Abstract][Full Text] [Related]
20. The regulation of stearoyl-CoA desaturase (SCD).
Ntambi JM
Prog Lipid Res; 1995; 34(2):139-50. PubMed ID: 7480063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
